A citation-based method for searching scientific literature

Adam Hudson Buchanan, Alanna Kulchak Rahm, Janet L Williams. Front Oncol 2016
Times Cited: 55







List of co-cited articles
370 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer.
Pedro Isaacsson Velho, John L Silberstein, Mark C Markowski, Jun Luo, Tamara L Lotan, William B Isaacs, Emmanuel S Antonarakis. Prostate 2018
51
5

Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines.
Piper Nicolosi, Elisa Ledet, Shan Yang, Scott Michalski, Brandy Freschi, Erin O'Leary, Edward D Esplin, Robert L Nussbaum, Oliver Sartor. JAMA Oncol 2019
79
5


Genetic Counseling and Testing in a Community Setting: Quality, Access, and Efficiency.
Stephanie A Cohen, Angela Bradbury, Vida Henderson, Kent Hoskins, Erica Bednar, Banu K Arun. Am Soc Clin Oncol Educ Book 2019
19
15

Current conditions in medical genetics practice.
Deborah R Maiese, Alisha Keehn, Megan Lyon, David Flannery, Michael Watson. Genet Med 2019
41
7

Genetic Counseling Service Delivery Models in the United States: Assessment of changes in use from 2010 to 2017.
Samantha E Greenberg, Emily Boothe, Christine L Delaney, Ryan Noss, Stephanie A Cohen. J Genet Couns 2020
10
30


Reducing death from melanoma and standards of evidence.
Martin A Weinstock. J Invest Dermatol 2012
12
16


Impact of direct-to-consumer genomic testing at long term follow-up.
Cinnamon S Bloss, Nathan E Wineinger, Burcu F Darst, Nicholas J Schork, Eric J Topol. J Med Genet 2013
100
3

How much melanoma is caused by sun exposure?
B K Armstrong, A Kricker. Melanoma Res 1993
326
3

Reduced melanoma after regular sunscreen use: randomized trial follow-up.
Adèle C Green, Gail M Williams, Valerie Logan, Geoffrey M Strutton. J Clin Oncol 2011
378
3

Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours.
Theresa M Marteau, David P French, Simon J Griffin, A T Prevost, Stephen Sutton, Clare Watkinson, Sophie Attwood, Gareth J Hollands. Cochrane Database Syst Rev 2010
197
3

Exploring the Potential Emotional and Behavioural Impact of Providing Personalised Genomic Risk Information to the Public: A Focus Group Study.
Amelia K Smit, Louise A Keogh, Ainsley J Newson, Jolyn Hersch, Phyllis Butow, Anne E Cust. Public Health Genomics 2015
12
16

Public health implications from COGS and potential for risk stratification and screening.
Hilary Burton, Susmita Chowdhury, Tom Dent, Alison Hall, Nora Pashayan, Paul Pharoah. Nat Genet 2013
84
3

Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group.
Richard R Fabsitz, Amy McGuire, Richard R Sharp, Mona Puggal, Laura M Beskow, Leslie G Biesecker, Ebony Bookman, Wylie Burke, Esteban Gonzalez Burchard, George Church,[...]. Circ Cardiovasc Genet 2010
280
3

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.
Jonathan Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Gordon Rustin, Clare L Scott, Werner Meier, Ronnie Shapira-Frommer, Tamar Safra,[...]. Lancet Oncol 2014
841
3

Variants of uncertain significance in BRCA: a harbinger of ethical and policy issues to come?
Jae Yeon Cheon, Jessica Mozersky, Robert Cook-Deegan. Genome Med 2014
54
3

The legal risks of returning results of genomics research.
Ellen Wright Clayton, Amy L McGuire. Genet Med 2012
87
3

Awareness of cancer susceptibility genetic testing: the 2000, 2005, and 2010 National Health Interview Surveys.
Phuong L Mai, Susan Thomas Vadaparampil, Nancy Breen, Timothy S McNeel, Louise Wideroff, Barry I Graubard. Am J Prev Med 2014
69
3

Cancer genetic risk assessment and referral patterns in primary care.
Hetal S Vig, Joanne Armstrong, Brian L Egleston, Carla Mazar, Michele Toscano, Angela R Bradbury, Mary B Daly, Neal J Meropol. Genet Test Mol Biomarkers 2009
41
4

Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
Matthew B Yurgelun, Brian Allen, Rajesh R Kaldate, Karla R Bowles, Thaddeus Judkins, Praveen Kaushik, Benjamin B Roa, Richard J Wenstrup, Anne-Renee Hartman, Sapna Syngal. Gastroenterology 2015
142
3


Comparing universal Lynch syndrome tumor-screening programs to evaluate associations between implementation strategies and patient follow-through.
Deborah Cragun, Rita D DeBate, Susan T Vadaparampil, Julie Baldwin, Heather Hampel, Tuya Pal. Genet Med 2014
45
4

Participation of low-income women in genetic cancer risk assessment and BRCA 1/2 testing: the experience of a safety-net institution.
Ian K Komenaka, Jesse N Nodora, Lisa Madlensky, Lisa M Winton, Meredith A Heberer, Richard B Schwab, Jeffrey N Weitzel, Maria Elena Martinez. J Community Genet 2016
25
8

Cancer risk assessment using genetic panel testing: considerations for clinical application.
Susan Hiraki, Erica S Rinella, Freya Schnabel, Ruth Oratz, Harry Ostrer. J Genet Couns 2014
27
7


Technical report: Ethical and policy issues in genetic testing and screening of children.
Lainie Friedman Ross, Howard M Saal, Karen L David, Rebecca R Anderson. Genet Med 2013
254
3

Uptake of genetic testing by relatives of lynch syndrome probands: a systematic review.
Ravi N Sharaf, Parvathi Myer, Christopher D Stave, Lisa C Diamond, Uri Ladabaum. Clin Gastroenterol Hepatol 2013
78
3

Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.
Kasmintan A Schrader, Donavan T Cheng, Vijai Joseph, Meera Prasad, Michael Walsh, Ahmet Zehir, Ai Ni, Tinu Thomas, Ryma Benayed, Asad Ashraf,[...]. JAMA Oncol 2016
161
3

Massively parallel sequencing: the next big thing in genetic medicine.
Tracy Tucker, Marco Marra, Jan M Friedman. Am J Hum Genet 2009
185
3


Evolution of Hereditary Breast Cancer Genetic Services: Are Changes Reflected in the Knowledge and Clinical Practices of Florida Providers?
Deborah Cragun, Courtney Scherr, Lucia Camperlengo, Susan T Vadaparampil, Tuya Pal. Genet Test Mol Biomarkers 2016
11
18

Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk.
C Hughes, A Gomez-Caminero, J Benkendorf, J Kerner, C Isaacs, J Barter, C Lerman. Patient Educ Couns 1997
163
3


Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.
Marc D Schwartz, Caryn Lerman, Barbara Brogan, Beth N Peshkin, Claudine Isaacs, Tiffani DeMarco, Chanita Hughes Halbert, Marie Pennanen, Clinton Finch. Cancer Epidemiol Biomarkers Prev 2005
66
3




Design and implementation of a randomized controlled trial of genomic counseling for patients with chronic disease.
Kevin Sweet, Erynn S Gordon, Amy C Sturm, Tara J Schmidlen, Kandamurugu Manickam, Amanda Ewart Toland, Margaret A Keller, Catharine B Stack, J Felipe García-España, Mark Bellafante,[...]. J Pers Med 2014
16
12

Upending the social ecological model to guide health promotion efforts toward policy and environmental change.
Shelley D Golden, Kenneth R McLeroy, Lawrence W Green, Jo Anne L Earp, Lisa D Lieberman. Health Educ Behav 2015
58
3

From genetic counseling to "genomic counseling".
Kelly E Ormond. Mol Genet Genomic Med 2013
43
4


EMR documentation of physician-patient communication following genomic counseling for actionable complex disease and pharmacogenomic results.
K Sweet, A C Sturm, T Schmidlen, S Hovick, J Peng, K Manickam, A Salikhova, J McElroy, L Scheinfeldt, A E Toland,[...]. Clin Genet 2017
6
33

Cancer genetic risk assessment for individuals at risk of familial breast cancer.
Jennifer S Hilgart, Bernadette Coles, Rachel Iredale. Cochrane Database Syst Rev 2012
49
4

Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer.
Jonathan Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Gordon Rustin, Clare Scott, Werner Meier, Ronnie Shapira-Frommer, Tamar Safra,[...]. N Engl J Med 2012
3

The Angelina effect: immediate reach, grasp, and impact of going public.
Dina L G Borzekowski, Yue Guan, Katherine C Smith, Lori H Erby, Debra L Roter. Genet Med 2014
90
3

Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas.
Kathryn P Pennington, Tom Walsh, Maria I Harrell, Ming K Lee, Christopher C Pennil, Mara H Rendi, Anne Thornton, Barbara M Norquist, Silvia Casadei, Alexander S Nord,[...]. Clin Cancer Res 2014
484
3

Hereditary ovarian cancer: beyond the usual suspects.
Kathryn P Pennington, Elizabeth M Swisher. Gynecol Oncol 2012
79
3

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
Tom Walsh, Silvia Casadei, Ming K Lee, Christopher C Pennil, Alex S Nord, Anne M Thornton, Wendy Roeb, Kathy J Agnew, Sunday M Stray, Anneka Wickramanayake,[...]. Proc Natl Acad Sci U S A 2011
564
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.